Cite
HARVARD Citation
Zabkiewicz, J. et al. (2020). Combination of a mitogen‐activated protein kinase inhibitor with the tyrosine kinase inhibitor pacritinib combats cell adhesion‐based residual disease and prevents re‐expansion of FLT3‐ITD acute myeloid leukaemia. British journal of haematology. pp. 231-242. [Online].